tm logo
Trademark Search
T-DETECT

View On IC.GC.CA

T-DETECT
REGISTERED

on 18 Oct 2024

Last Applicant/ Owned by

ADAPTIVE BIOTECHNOLOGIES CORPORATION

1551 Eastlake Avenue East, Suite 200Seattle, WA 98102

US

Serial Number

2068563 filed on 04th Dec 2020

Registration Number

TMA1263856 registered on 18th Oct 2024

Registration expiry Date

18th Oct 2034

Correspondent Address

SUITE 2308120 ADELAIDE STREET WESTTORONTO

ONTARIO

CA

M5H1T1

T-DETECT

Trademark usage description

diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect canc Read More

Classification Information

Class [005]
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; medical diagnostic assay kits comprised of diagnostic reagents and assays for medical use, namely, to detect cancer, autoimmune disease and infection; diagnostic kits comprised of medical immunosequencing-based diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; medical immunosequencing assay kits comprised of diagnostic reagents and assays for medical use, namely, to detect cancer, autoimmune disease and infection; reagents and assays for testing bodily fluids; medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection

Classification kind code

11

Class [042]
Medical laboratory services; laboratory research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; consulting services in the fields of medical laboratory testing, diagnostics, and pharmacogenetics; medical research laboratory services in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; providing information about medical research in the field medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of laboratory testing, diagnostics, and pharmacogenetics

Classification kind code

11

Class [044]
Medical diagnostic services; medical diagnostic testing, monitoring and reporting services; medical imaging services; medical testing services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical care and analysis services relating to patient treatment; medical laboratory services for the analysis of blood samples taken from patients; medical diagnostic testing, monitoring and reporting services; providing medical immunosequencing-based testing for cancer, autoimmune disease and infection; consulting services in the field of medical immunosequencing-based testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical laboratory immunosequencing-based services for analysis of biological samples; information, advisory and consultancy services in the field of medical care and analysis services; consulting services in the field of medical diagnostic and prognostic testing; providing medical diagnostic and prognostic testing services

Classification kind code

11

Mark Details

Serial Number

2068563

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 18th Oct 2024		Registration Pending
Submitted for opposition 42
on 31st Jul 2024		Advertised
Submitted for opposition 27
on 18th Jun 2024		Approval Notice Sent
Submitted for opposition 26
on 18th Jun 2024		Approved
Submitted for opposition 22
on 13th Apr 2023		Search Recorded
Submitted for opposition 20
on 13th Apr 2023		Examiner's First Report
Submitted for opposition 287
on 19th May 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 04th Dec 2020		Filed
Submitted for opposition 1
on 04th Dec 2020		Created
Submitted for opposition 31
on 04th Dec 2020		Formalized